Home Life Sciences Post-transcriptional regulation of human cathepsin L expression
Article
Licensed
Unlicensed Requires Authentication

Post-transcriptional regulation of human cathepsin L expression

  • Shivani Mittal , Riyaz A. Mir and Shyam S. Chauhan EMAIL logo
Published/Copyright: June 18, 2011
Biological Chemistry
From the journal Volume 392 Issue 5

Abstract

The expression of cathepsin L, a lysosomal protease, is known to be elevated in cancer and other pathologies. Multiple splice variants of human cathepsin L with variable 5′UTRs exist, which encode for the same protein. Previously we have observed that variant hCATL A (bearing the longest 5′UTR) was translated in vitro with significantly lower efficiency than variant hCATL AIII (bearing the shortest 5′UTR). Contrary to these findings, results of the present study reveal that in cancer cells, hCATL A mRNA exhibits higher translatability in spite of having lower stability than AIII. This is the first report demonstrating a highly contrasting trend in translation efficiencies of hCATL variants in rabbit reticulocytes and live cells. Expression from chimeric mRNAs containing 5′UTRs of A or AIII upstream to luciferase reporter cDNA established the A UTR to be the sole determinant for this effect. Transient transfections of bicistronic plasmids and mRNAs confirmed the presence of a functional Internal Ribosome Entry Site in this UTR. Our data suggest that differential stability and translation initiation modes mediated by the 5′UTRs of human cathepsin L variants are involved in regulating its expression.


Corresponding author

Received: 2010-7-20
Accepted: 2010-12-13
Published Online: 2011-06-18
Published in Print: 2011-05-01

©2011 by Walter de Gruyter Berlin New York

Downloaded on 8.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/bc.2011.039/html
Scroll to top button